Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 5/2012

01-10-2012 | Clinical Investigation

Effectiveness of Repeat Angiographic Assessment in Patients Designated for Radioembolization Using Yttrium-90 Microspheres With Initial Extrahepatic Accumulation of Technitium-99m Macroaggregated Albumin: A Single Center’s Experience

Authors: Oliver Dudeck, Skadi Wilhelmsen, Gerhard Ulrich, David Löwenthal, Maciej Pech, Holger Amthauer, Jens Ricke

Published in: CardioVascular and Interventional Radiology | Issue 5/2012

Login to get access

Abstract

Purpose

To evaluate the efficacy of a workflow consisting of repeat assessment in patients planned for yttrium-90 (90Y) radioembolization in case of nontarget visceral technetium-99m (99mTc)-macroaggregated albumin (MAA) accumulation despite initial prophylactic coil embolization of nonhepatic arteries.

Materials and Methods

In 341 patients with primary and secondary liver cancer, pretreatment hepatic angiograms, as well as single-photon emission computed tomography coregistered with magnetic resonance imaging scans, were obtained. Extrahepatic tracer deposition was identified in 33 patients (9.7%) necessitating repeat assessment. Images were reviewed to correlate the site of MAA accumulation with causative gastrointestinal vessels, and repeat angiograms served as reference standard.

Results

At repeat angiography, the source of extrahepatic flow was identified and eliminated in 31 of 33 patients (93.9%). In 20 patients (60.6%), successful embolization of nontarget vessels was achieved, in 13 patients (39.4%), MAA was administered more distally. Afterward, extrahepatic MAA deposition was eliminated in 30 patients (90.9%).

Conclusion

The algorithm of repeat assessment in case of extrahepatic MAA accumulation has proven highly effective to eliminate extrahepatic shunting, thus decreasing the risk of postradioembolization complications due to inadvertent visceral microsphere deposition.
Literature
1.
go back to reference Jakobs TF, Hoffmann RT, Poepperl G, Schmitz A, Lutz J, Koch W, Tatsch K, Lubiensky A, Reiser MF, Helmberger T (2007) Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 17:1320–1330PubMedCrossRef Jakobs TF, Hoffmann RT, Poepperl G, Schmitz A, Lutz J, Koch W, Tatsch K, Lubiensky A, Reiser MF, Helmberger T (2007) Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 17:1320–1330PubMedCrossRef
2.
go back to reference Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA Jr, Barakat O, Benson A III, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres—safety, efficacy, and survival. Radiology 247:507–515PubMedCrossRef Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA Jr, Barakat O, Benson A III, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres—safety, efficacy, and survival. Radiology 247:507–515PubMedCrossRef
3.
go back to reference Kennedy AS, Salem R (2010) Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Cancer J 16:163–175PubMedCrossRef Kennedy AS, Salem R (2010) Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Cancer J 16:163–175PubMedCrossRef
4.
go back to reference Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, Lam MG, Het Schip AD, Nijsen JF (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19:951–959PubMedCrossRef Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, Lam MG, Het Schip AD, Nijsen JF (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19:951–959PubMedCrossRef
5.
go back to reference Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213PubMedCrossRef Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213PubMedCrossRef
6.
go back to reference Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakat O, Sergie Z, Wong CY, Thurston KG (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639PubMedCrossRef Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakat O, Sergie Z, Wong CY, Thurston KG (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639PubMedCrossRef
7.
go back to reference Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME (2005) Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S41–S55PubMedCrossRef Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME (2005) Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S41–S55PubMedCrossRef
8.
go back to reference Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M (2007) Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553–561PubMedCrossRef Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M (2007) Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553–561PubMedCrossRef
9.
go back to reference Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A III, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the Radioembolization Brachytherapy Oncology Consortium. Int J Radiat Oncol Biol Physiol 68:13–23CrossRef Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A III, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the Radioembolization Brachytherapy Oncology Consortium. Int J Radiat Oncol Biol Physiol 68:13–23CrossRef
10.
go back to reference Sjoquist KM, Goldstein D, Bester L (2010) A serious complication of selected internal radiation therapy: case report and literature review. Oncologist 15:830–835PubMedCrossRef Sjoquist KM, Goldstein D, Bester L (2010) A serious complication of selected internal radiation therapy: case report and literature review. Oncologist 15:830–835PubMedCrossRef
11.
go back to reference Deleporte A, Flamen P, Hendlisz A (2010) State of the art: radiolabeled microspheres treatment for liver malignancies. Expert Opin Pharmacother 11:579–586PubMedCrossRef Deleporte A, Flamen P, Hendlisz A (2010) State of the art: radiolabeled microspheres treatment for liver malignancies. Expert Opin Pharmacother 11:579–586PubMedCrossRef
12.
go back to reference Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R (2007) Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30:571–592PubMedCrossRef Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R (2007) Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30:571–592PubMedCrossRef
13.
go back to reference Covey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224:542–547PubMedCrossRef Covey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224:542–547PubMedCrossRef
14.
go back to reference Kim HC, Chung JW, Lee W, Jae HJ, Park JH (2005) Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 25(Suppl 1):S25–S39PubMedCrossRef Kim HC, Chung JW, Lee W, Jae HJ, Park JH (2005) Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 25(Suppl 1):S25–S39PubMedCrossRef
15.
go back to reference Paprottka PM, Jakobs TF, Reiser MF, Hoffmann RT (2011) Practical vascular anatomy in the preparation of radioembolization. Cardiovasc Intervent Radiol. doi:10.1007/s00270-011-0169-z Paprottka PM, Jakobs TF, Reiser MF, Hoffmann RT (2011) Practical vascular anatomy in the preparation of radioembolization. Cardiovasc Intervent Radiol. doi:10.​1007/​s00270-011-0169-z
16.
go back to reference Denecke T, Ruhl R, Hildebrandt B, Stelter L, Grieser C, Stiepani H, Werk M, Podrabsky P, Plotkin M, Amthauer H, Ricke J, Lopez HE (2008) Planning transarterial radioembolization of colorectal liver metastases with yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques. Eur Radiol 18:892–902PubMedCrossRef Denecke T, Ruhl R, Hildebrandt B, Stelter L, Grieser C, Stiepani H, Werk M, Podrabsky P, Plotkin M, Amthauer H, Ricke J, Lopez HE (2008) Planning transarterial radioembolization of colorectal liver metastases with yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques. Eur Radiol 18:892–902PubMedCrossRef
17.
go back to reference Hamami ME, Poeppel TD, Muller S, Heusner T, Bockisch A, Hilgard P, Antoch G et al (2009) SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med 50:688–692PubMedCrossRef Hamami ME, Poeppel TD, Muller S, Heusner T, Bockisch A, Hilgard P, Antoch G et al (2009) SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med 50:688–692PubMedCrossRef
18.
go back to reference Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, Wilhelm K, Biersack HJ, Ezziddin S (2010) The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med 51:1206–1212PubMedCrossRef Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, Wilhelm K, Biersack HJ, Ezziddin S (2010) The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med 51:1206–1212PubMedCrossRef
19.
go back to reference South CD, Meyer MM, Meis G, Kim EY, Thomas FB, Rikabi AA, Khabiri H, Bloomston M (2008) Yttrium-90 microsphere induced gastrointestinal tract ulceration. World J Surg Oncol 6:93PubMedCrossRef South CD, Meyer MM, Meis G, Kim EY, Thomas FB, Rikabi AA, Khabiri H, Bloomston M (2008) Yttrium-90 microsphere induced gastrointestinal tract ulceration. World J Surg Oncol 6:93PubMedCrossRef
20.
go back to reference Yip D, Allen R, Ashton C, Jain S (2004) Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 19:347–349PubMedCrossRef Yip D, Allen R, Ashton C, Jain S (2004) Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 19:347–349PubMedCrossRef
21.
go back to reference Liu DM, Salem R, Bui JT, Courtney A, Barakat O, Sergie Z, Atassi B, Barrett K, Gowland P, Oman B, Lewandowski RJ, Gates VL, Thurston KG, Wong CY (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935PubMedCrossRef Liu DM, Salem R, Bui JT, Courtney A, Barakat O, Sergie Z, Atassi B, Barrett K, Gowland P, Oman B, Lewandowski RJ, Gates VL, Thurston KG, Wong CY (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935PubMedCrossRef
22.
go back to reference Abdelmaksoud MH, Hwang GL, Louie JD, Kothary N, Hofmann LV, Kuo WT, Hovsepian DM, Sze DY (2010) Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization. J Vasc Interv Radiol 21:1385–1395PubMedCrossRef Abdelmaksoud MH, Hwang GL, Louie JD, Kothary N, Hofmann LV, Kuo WT, Hovsepian DM, Sze DY (2010) Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization. J Vasc Interv Radiol 21:1385–1395PubMedCrossRef
23.
go back to reference Pech M, Kraetsch A, Wieners G, Redlich U, Gaffke G, Ricke J, Dudeck O et al (2009) Embolization of the gastroduodenal artery before selective internal radiotherapy: a prospectively randomized trial comparing platinum-fibered microcoils with the Amplatzer Vascular Plug II. Cardiovasc Intervent Radiol 32:455–461PubMedCrossRef Pech M, Kraetsch A, Wieners G, Redlich U, Gaffke G, Ricke J, Dudeck O et al (2009) Embolization of the gastroduodenal artery before selective internal radiotherapy: a prospectively randomized trial comparing platinum-fibered microcoils with the Amplatzer Vascular Plug II. Cardiovasc Intervent Radiol 32:455–461PubMedCrossRef
24.
go back to reference Inaba Y, Arai Y, Matsueda K, Takeuchi Y, Aramaki T (2001) Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 12:957–963PubMedCrossRef Inaba Y, Arai Y, Matsueda K, Takeuchi Y, Aramaki T (2001) Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 12:957–963PubMedCrossRef
25.
go back to reference Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, Murthy R, Ryu RK, Sato KT, Miller FH, Omary RA, Salem R (2008) Biliary sequelae following radioembolization with yttrium-90 microspheres. J Vasc Interv Radiol 19:691–697PubMedCrossRef Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, Murthy R, Ryu RK, Sato KT, Miller FH, Omary RA, Salem R (2008) Biliary sequelae following radioembolization with yttrium-90 microspheres. J Vasc Interv Radiol 19:691–697PubMedCrossRef
26.
go back to reference Williams DM, Cho KJ, Ensminger WD, Ziessman HA, Gyves JW (1985) Hepatic falciform artery: anatomy, angiographic appearance, and clinical significance. Radiology 156:339–340PubMed Williams DM, Cho KJ, Ensminger WD, Ziessman HA, Gyves JW (1985) Hepatic falciform artery: anatomy, angiographic appearance, and clinical significance. Radiology 156:339–340PubMed
27.
go back to reference Gibo M, Hasuo K, Inoue A, Miura N, Murata S (2001) Hepatic falciform artery: angiographic observations and significance. Abdom Imaging 26:515–519PubMedCrossRef Gibo M, Hasuo K, Inoue A, Miura N, Murata S (2001) Hepatic falciform artery: angiographic observations and significance. Abdom Imaging 26:515–519PubMedCrossRef
28.
go back to reference Kim DE, Yoon HK, Ko GY, Kwon JS, Song HY, Sung KB (1999) Hepatic falciform artery: is prophylactic embolization needed before short-term hepatic arterial chemoinfusion? AJR Am J Roentgenol 172:1597–1599PubMed Kim DE, Yoon HK, Ko GY, Kwon JS, Song HY, Sung KB (1999) Hepatic falciform artery: is prophylactic embolization needed before short-term hepatic arterial chemoinfusion? AJR Am J Roentgenol 172:1597–1599PubMed
Metadata
Title
Effectiveness of Repeat Angiographic Assessment in Patients Designated for Radioembolization Using Yttrium-90 Microspheres With Initial Extrahepatic Accumulation of Technitium-99m Macroaggregated Albumin: A Single Center’s Experience
Authors
Oliver Dudeck
Skadi Wilhelmsen
Gerhard Ulrich
David Löwenthal
Maciej Pech
Holger Amthauer
Jens Ricke
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
CardioVascular and Interventional Radiology / Issue 5/2012
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-011-0252-5

Other articles of this Issue 5/2012

CardioVascular and Interventional Radiology 5/2012 Go to the issue

Letter to the Editor

Management of Gastric Varices